Epilepsy Clinical Trials in Nashville, Tennessee

5 studies are recruiting for epilepsy in Nashville, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

   This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Vanderbilt University Medical Center, Nashville, Tennessee

   Locations

   11 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07594119 on ClinicalTrials.gov

2. Physiological Brain Atlas Development

   The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essentia…

   Stage

   Not phased

   Ages

   6 to 90

   Site

   Vanderbilt Univeristy, Nashville, Tennessee

   Run by

   Vanderbilt University Medical Center

   See if you can join NCT00575081 on ClinicalTrials.gov

3. Subcortical Arousal in Perceptual Awareness

   The study consists of prospective enrollment of healthy participants and patients with epilepsy, as well as analysis of an existing data set. Healthy participants will be studied with fMRI, eye metrics and behavioral testing at Yale. Patients will be studied with intracranial thalamic and cortical …

   Stage

   Not phased

   Ages

   13 and older

   Site

   Vanderbilt University Medical Center, Nashville, Tennessee

   Locations

   8 in total

   Run by

   Yale University

   See if you can join NCT06934356 on ClinicalTrials.gov

4. Effect of Rose Odor Exposure on Ictal Apnea

   This study will investigate the potential benefits of rose scent in reducing the risk of Sudden Unexpected Death in Epilepsy (SUDEP) in patients with epilepsy. Participants will engage in their routine inpatient observational EEG monitoring for 24 hours followed by an additional 24 hours of observa…

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   Vanderbilt University Medical Center, Nashville, Tennessee

   Run by

   Vanderbilt University Medical Center

   See if you can join NCT07116421 on ClinicalTrials.gov

5. A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

   This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   Vanderbilt University Medical Center, Nashville, Tennessee

   Locations

   7 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07219407 on ClinicalTrials.gov